This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Hoffmann-La Roche Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations by Christian Weile
Introduction
Christian Weile is an accomplished inventor based in Farum, Denmark. He has made significant contributions to the field of molecular biology, particularly in the development of antisense oligonucleotides. His work focuses on addressing the challenges posed by TDP-43 depletion in cells.
Latest Patents
Christian Weile holds a patent for "Oligonucleotides targeting RNA binding protein sites." This invention relates to antisense oligonucleotides that are complementary to conserved TDP-43 binding sites on pre-mRNA transcripts. These oligonucleotides are capable of restoring RNA binding protein function in the processing of multiple independent mRNAs in TDP-43 depleted cells. He has 1 patent to his name.
Career Highlights
Christian Weile is associated with Hoffmann-La Roche Inc., a leading global healthcare company. His work at the company has allowed him to contribute to innovative solutions in the field of RNA biology.
Collaborations
Christian has collaborated with notable colleagues, including Congwei Wang and Meiling Li, who is a prominent female scientist in the field.
Conclusion
Christian Weile's innovative work in developing antisense oligonucleotides showcases his commitment to advancing molecular biology. His contributions are vital for understanding and addressing RNA binding protein functions in cellular processes.